Expecting mothers who suffer from allergies may want to consider another vaccination in addition to the flu shot and Tdap. A study presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) found pregnant women who receive allergy shots, also known as immunotherapy, during pregnancy may decrease their baby’s chance of developing allergies.
“Our research found trends suggesting women receiving allergy shots either before or during pregnancy reduced their child’s chances of having asthma, food allergies, or eczema,” said allergist Jay Lieberman, MD, ACAAI member. “Prior studies have suggested that mothers can pass protective factors to their fetus that may decrease their child’s chance of developing allergic disease, and these protective factors are increased with allergy immunotherapy.”
While there is no cure for the more than 50 million Americans suffering from allergies, immunotherapy is known to modify and prevent disease progression.
According to ACAAI, allergies tend to run in families. If both parents have allergies, their children have a 75 percent chance of being allergic. If only one parent is allergic, or if a relative has allergies, the child has a 30 to 40 percent chance of having an allergy. If neither parent has allergy, the chance of a child developing an allergy is only 10 to15 percent.
“Allergy shots are not only effective but cost efficient,” said allergist Warner Carr, MD, chair of the ACAAI Immunotherapy and Diagnostics Committee. “Immunotherapy can result in health care savings of 33 to 41 percent.”